Discharge Education in Diabetic Surgical Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Personalised Discharge training: Discharge education also contributes to the empowerment of diabetic surgery patients in diabetes management. During the training process, patients will be informed about blood glucose control, diet, exercise and medication management.
Study summary
In the literature, it is seen that the discharge education given to patients with diabetes is especially focused on the effects of blood glucose control and self-efficacy, and there is no study examining the effects of discharge education on diabetes empowerment with a more general perspective in diabetes patients in surgical processes. In this context, the study was designed to examine the effects of diabetes-based personalised discharge education given to surgical patients on satisfaction and diabetes empowerment.
Eligibility
Primary outcome measure(s)
- Satisfaction with Discharge Training — through study completion, an average of 1 year
It will be measured with the Discharge Training Satisfaction Scale Specific to Surgical Patients. Satisfaction will be measured with the 'Discharge Training Satisfaction Scale'. It consists of 21 items in a 5-point Likert scale. The scale does not contain negative items. The lowest score of 21 points and the highest score of 105 points can be obtained from the scale. - diabetes empowerment — through study completion, an average of 1 year
The ability to manage the disease will be measured with the Diabetes Empowerment Scale. There are 28 items in Diabetes Empowerment Scale. Five-point Likert type (1: Strongly disagree, 5: Strongly agree), items 18,20,21,22,23,24,25,26 and 27 of this scale are under the sub-dimension of 'Self-awareness-managing psychological aspects of illness'; items 1,2,3,4,15,16,17 and 19 are under the sub-dimension of 'Ability to achieve goals'; items 5,6,7,8,9,10,11,12,13 and 14 are under the sub-dimension of 'Ability to set goals'. The minimum score of the scale is 28 and the maximum score is 140. A score between 28-65 points indicates a low level of resilience, 66-103 indicates a medium level, and 104-140 indicates a high level of resilience.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Abant Izzet Baysal University Faculty of Health Science | Bolu | Merkez |
More Abant Izzet Baysal University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06777836 on ClinicalTrials.gov ↗ ← All trials in Turkey